Immunohistochemistry Market Size, Industry Analysis, Trends, Growth, Market Share and Forecast 2024 to 2029
The global immunohistochemistry (IHC) market is experiencing steady growth, with a compound annual growth rate (CAGR) of approximately 7-8%. This expansion is largely driven by the increasing prevalence of cancer and chronic diseases, rising demand for personalized medicine, and advancements in diagnostic technologies. Additionally, IHC’s growing role in research for drug development and its critical application in disease diagnostics, particularly in oncology and infectious diseases, are further boosting demand. However, the market faces challenges, including the high costs of IHC testing and the complexity of interpreting results, which may limit broader adoption. To learn more about the research report, download a sample report.
Report Overview
Immunohistochemistry is a vital laboratory technique that combines histological, immunological, and biochemical methods to detect specific antigens in tissue sections. By utilizing antibodies that bind to these antigens and tagging them with enzymes or fluorescent dyes, IHC enables the visualization and localization of proteins within tissues. This technique plays a critical role in diagnosing diseases such as cancer, where specific protein markers help determine the type, grade, and prognosis of tumours. Widely used in medical diagnostics and research, IHC provides detailed insights into cellular processes and disease states, making it an essential tool for both clinicians and researchers in pathology and molecular biology.
To learn more about this report, download the PDF brochure
The Expanding Need for IHC in Modern Diagnostics
A key factor driving the growth of the immunohistochemistry market is the increasing prevalence of cancer worldwide. IHC's ability to detect cancer-specific biomarkers allows for more accurate diagnosis, treatment planning, and disease monitoring, making it an essential tool in oncology. With the rise in cancer cases, the demand for precise and early diagnostic methods like IHC continues to grow. This technique helps identify tumour markers, facilitating more informed treatment decisions and better patient outcomes. Additionally, the expansion of personalized medicine, technological advancements such as automated platforms and multiplexing, and the aging global population further contribute to the market’s growth, as these factors drive the need for advanced diagnostic tools.
Innovations in Automation and AI Drive IHC Market Growth
A prominent trend fuelling the growth of the immunohistochemistry market is the advancement of automation technologies and the integration of digital pathology. Automated IHC systems improve the efficiency and accuracy of testing by reducing human error and accelerating processes, allowing for higher throughput in laboratories. This is particularly beneficial for large-scale diagnostic and research applications, where consistency and speed are crucial. Additionally, the integration of IHC with digital pathology enables the digital scanning of tissue samples, facilitating more detailed analysis and enhanced image management. The incorporation of AI into this process further boosts diagnostic accuracy, offering predictive insights and advancing personalized treatment approaches. These advancements are transforming diagnostic workflows, making IHC more efficient and reliable across clinical and research settings.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global immunohistochemistry market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; PerkinElmer, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Bio SB; and Abcam plc among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
|
Report Scope |
Details |
|
Base Year Considered |
2023 |
|
Historical Data |
2022 - 2023 |
|
Forecast Period |
2024 - 2029 |
|
Growth Rate |
7-8% |
|
Segment Scope |
Product, Application, End User |
|
Regional Scope |
|
|
Key Companies Mapped |
F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; PerkinElmer, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Bio SB; and Abcam plc among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Key Strategic Questions Addressed
-
What is the market size & forecast of the immunohistochemistry market?
-
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the immunohistochemistry market?
-
What are the key trends defining the market?
-
What are the major factors impacting the market?
-
What are the opportunities prevailing in the market?
-
Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
-
Who are the major players operating in the market?
-
What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Immunohistochemistry (IHC) Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising incidence of cancer and chronic diseases
- Growing demand for personalized medicine
- Technological advancements in IHC
- Increased focus on early disease detection and prevention
- Expansion of immuno-oncology and biomarker-driven drug development
- Restraints
- High costs of IHC instruments and reagents
- Limited reimbursement policies for diagnostic tests
- Lack of skilled professionals in emerging regions
- Opportunities
- Rising investment in emerging markets for healthcare infrastructure
- Expanding applications in pharmaceutical and biotech research
- Key Market Trends
- Integration of IHC with AI and digital pathology for enhanced diagnostic accuracy
- Shift towards high-throughput, fully automated IHC systems in labs
- Unmet Market Needs
- Industry Speaks
- Regulatory Analysis
- Drivers
- Market Dynamics
- Global Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By Product, USD Million
- Introduction
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining System
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
- Reagents
- Histological stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
- Global Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By Application, USD Million
- Introduction
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Research
- Global Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By End User, USD Million
- Introduction
- Hospitals
- Diagnostic Centers
- Academic and Research Institutes
- Others
- Global Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By Region, USD Million
- Introduction
- North America Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- North America Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By Country, USD Million
- Introduction
-
-
- Asia Pacific (APAC) Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Asia Pacific (APAC) Immunohistochemistry (IHC) Market Size & Forecast (2022-2029), By Country, USD Million
-
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2023)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- Bio SB
- Abcam plc.
- Other Prominent Players
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Hospitals, Diagnostic Centers, Academic and Research Institutes and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
